LFSC vs. PPH
Compare and contrast key facts about F/m Emerald Life Sciences Innovation ETF (LFSC) and VanEck Vectors Pharmaceutical ETF (PPH).
LFSC and PPH are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. LFSC is an actively managed fund by F/m Investments. It was launched on Oct 30, 2024. PPH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Pharmaceutical 25 Index. It was launched on Dec 20, 2011.
Performance
LFSC vs. PPH - Performance Comparison
Loading graphics...
LFSC vs. PPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
LFSC F/m Emerald Life Sciences Innovation ETF | -4.45% | 56.54% | -6.02% |
PPH VanEck Vectors Pharmaceutical ETF | 0.69% | 22.00% | -5.06% |
Returns By Period
In the year-to-date period, LFSC achieves a -4.45% return, which is significantly lower than PPH's 0.69% return.
LFSC
- 1D
- 6.16%
- 1M
- -3.82%
- YTD
- -4.45%
- 6M
- 17.66%
- 1Y
- 55.83%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PPH
- 1D
- 1.94%
- 1M
- -7.00%
- YTD
- 0.69%
- 6M
- 15.81%
- 1Y
- 16.30%
- 3Y*
- 12.44%
- 5Y*
- 10.59%
- 10Y*
- 8.04%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
LFSC vs. PPH - Expense Ratio Comparison
LFSC has a 0.54% expense ratio, which is higher than PPH's 0.36% expense ratio.
Return for Risk
LFSC vs. PPH — Risk / Return Rank
LFSC
PPH
LFSC vs. PPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for F/m Emerald Life Sciences Innovation ETF (LFSC) and VanEck Vectors Pharmaceutical ETF (PPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LFSC | PPH | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.93 | 0.83 | +1.09 |
Sortino ratioReturn per unit of downside risk | 2.65 | 1.26 | +1.39 |
Omega ratioGain probability vs. loss probability | 1.33 | 1.16 | +0.17 |
Calmar ratioReturn relative to maximum drawdown | 3.20 | 1.48 | +1.72 |
Martin ratioReturn relative to average drawdown | 8.96 | 4.08 | +4.88 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| LFSC | PPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.93 | 0.83 | +1.09 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.72 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.48 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.94 | 0.31 | +0.64 |
Correlation
The correlation between LFSC and PPH is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
LFSC vs. PPH - Dividend Comparison
LFSC has not paid dividends to shareholders, while PPH's dividend yield for the trailing twelve months is around 1.77%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LFSC F/m Emerald Life Sciences Innovation ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PPH VanEck Vectors Pharmaceutical ETF | 1.77% | 1.78% | 1.98% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% |
Drawdowns
LFSC vs. PPH - Drawdown Comparison
The maximum LFSC drawdown since its inception was -29.74%, smaller than the maximum PPH drawdown of -51.45%. Use the drawdown chart below to compare losses from any high point for LFSC and PPH.
Loading graphics...
Drawdown Indicators
| LFSC | PPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -29.74% | -51.45% | +21.71% |
Max Drawdown (1Y)Largest decline over 1 year | -16.25% | -10.02% | -6.23% |
Max Drawdown (5Y)Largest decline over 5 years | — | -20.26% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -29.70% | — |
Current DrawdownCurrent decline from peak | -11.08% | -7.00% | -4.08% |
Average DrawdownAverage peak-to-trough decline | -8.25% | -17.38% | +9.13% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.80% | 4.14% | +1.66% |
Volatility
LFSC vs. PPH - Volatility Comparison
F/m Emerald Life Sciences Innovation ETF (LFSC) has a higher volatility of 10.35% compared to VanEck Vectors Pharmaceutical ETF (PPH) at 5.11%. This indicates that LFSC's price experiences larger fluctuations and is considered to be riskier than PPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| LFSC | PPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.35% | 5.11% | +5.24% |
Volatility (6M)Calculated over the trailing 6-month period | 19.97% | 12.37% | +7.60% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.24% | 19.67% | +9.57% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.31% | 14.85% | +14.46% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.31% | 16.95% | +12.36% |